Study guide

20.3 Substance Use, Addictions, Withdrawal & Harm Reduction

COPR Primary Care Paramedic PCP

Track your progress as you read

Finished sections get a check mark.

1 Introduction: The COPR PCP Exam & How to Use This Guide

0.1 About the COPR PCP Entry-to-Practice Examination 0.2 The 2024 CPCF Blueprint: Competence Areas, Weights & Question Targets 0.3 Eligibility, Attempts, Accommodations & a 12-Week Study Plan

2 Chapter 1: Professionalism, Ethics & Legal Framework

1.1 Ethical Practice, Professionalism & Values in Canadian Paramedicine 1.2 Professional Accountability, Candour & Duty to Report 1.3 Regulatory Framework, Scope of Practice & Informed Consent

3 Chapter 2: Patient-Centred Communication & Clinical Documentation

2.1 Therapeutic Communication, Empathy & De-escalation 2.2 Patient-Centred Interviewing & Comprehensive History Gathering 2.3 Clinical Information Sharing, Consent & Incident Disclosure 2.4 Clinical Documentation, Electronic Health Records & Privacy 2.5 Shared Decision-Making, Health Literacy & Engaging Patients in Care Plans

4 Chapter 3: Interprofessional Collaboration & Continuum of Care

3.1 Care Team Roles, Task Delegation & Shared Decision-Making 3.2 Scene Collaboration, Interagency Conflict & Safety Culture 3.3 Safe Transfer of Care, Clinical Handover & Transition Plans

5 Chapter 4: Evidence-Informed Practice & Continuing Competence

4.1 Clinical Mentorship, Role Modelling & Reflective Debriefing 4.2 Evidence-Informed Practice, Guideline Translation & Lifelong Learning 4.3 Continuing Competence, Personal Learning Plans & Adapting to a Changing Profession

6 Chapter 5: Professional Health, Safety & Operational Resilience

5.1 Paramedic Wellness, Occupational Stress Injuries & PTSI Recognition 5.2 Fitness for Duty, Ergonomics, Safe Lifting & Peer Support Systems 5.3 Monitoring Personal Health, Healthy Coping & Removing Yourself from Practice

7 Chapter 6: Health Advocacy, Equity & Culturally Safe Care

6.1 Social Determinants of Health, Cultural Safety & Anti-Oppressive Practice 6.2 Anti-Indigenous Racism, Truth and Reconciliation & Trauma-Informed Care 6.3 System-Level Advocacy, Social Accountability & Working Toward Reconciliation

8 Chapter 7: Situational Leadership & Scene Operations

7.1 Prehospital Scene Assessment, Initial Incident Command & Hazard Mitigation 7.2 Clinical Resource Coordination & Practice Improvement Systems

9 Chapter 8: Infection Prevention, Diagnostics & Scene Preparedness

8.1 Infection Prevention and Control: Routine Practices, PPE & Sharps Safety 8.2 Point-of-Care Risk Assessment & Mass Casualty/CBRNE Principles 8.3 Paramedic Scope along the Continuum & Diagnostic Laboratory Correlation 8.4 Point-of-Care Risk Assessment, Situational Awareness & Securing Additional Resources

10 Chapter 9: Patient Assessment, Physical Examination & Vital Signs

9.1 Primary Survey, Rapid Trauma/Medical Exam & Threat Identification 9.2 Secondary Assessment, History Integration (SAMPLE/OPQRST) & Lifespan Adaptation 9.3 Vital Signs Interpretation, Glasgow Coma Scale & Clinical Reassessment

11 Chapter 10: Diagnostic Monitoring: ECG & Capnography

10.1 Prehospital Pulse Oximetry, Glucometry & Urinalysis 10.2 Prehospital Electrocardiography: 3-Lead Monitoring & 12-Lead Acquisition 10.3 Continuous Waveform Capnography (EtCO2) & Ventilation Dynamics

12 Chapter 11: Airway Management & Ventilation Therapeutics

11.1 Basic Airway Maneuvers, Positioning, OPA/NPA & Suctioning Techniques 11.2 Supraglottic Airway (SGA) Devices & Tracheostomy Management 11.3 Oxygen Delivery Modalities, Regulators & Safety 11.4 Positive Pressure Ventilation, BVM Mechanics, PEEP & CPAP 11.5 Foreign Body Airway Obstruction: Recognition & Relief Across the Lifespan 11.6 Beyond CPAP: BiPAP, High-Flow Nasal Cannula Therapy & Choosing a Ventilation Strategy

13 Chapter 12: Cardiovascular Emergencies & Resuscitative Care

12.1 High-Performance Cardiopulmonary Resuscitation (CPR) & Automated/Manual Defibrillation 12.2 Acute Coronary Syndromes (ACS), STEMI Recognition & Pathophysiology 12.3 Heart Failure, Cardiogenic Shock & Left Ventricular Assist Devices (LVAD) 12.4 Cardiovascular Pharmacotherapy: Nitroglycerin, ASA & Epinephrine

14 Chapter 13: Trauma Emergencies, Hemorrhage Control & SMR

13.1 External Hemorrhage Control: Tourniquets, Wound Packing & Pelvic Binders 13.2 Spinal Motion Restriction (SMR) & Canadian C-Spine Rule Application 13.3 Thoracic & Abdominal Trauma Management 13.4 Musculoskeletal Trauma, Fractures, Splinting & Dislocation Reduction 13.5 Head Injury & Traumatic Brain Injury: Preventing Secondary Brain Injury 13.6 Burns and Soft-Tissue Injury: Thermal, Chemical, Electrical & Inhalation

15 Chapter 14: Medical, Endocrine, Toxicological & Environmental Emergencies

14.1 Acute Respiratory Distress: Asthma, COPD, Pulmonary Edema & Anaphylaxis 14.2 Neurological Emergencies: Stroke Syndromes, TIA, Seizures & Status Epilepticus 14.3 Endocrine Emergencies: Hypoglycemia, DKA/HHS & Glucagon/Dextrose Administration 14.4 Toxicological Emergencies, Opioid Toxicity, Naloxone & Environmental Exposure 14.5 Abdominal, Gastrointestinal & Hepatobiliary Emergencies 14.6 Genitourinary, Renal & Dialysis Emergencies 14.7 Haematologic, Immunologic, EENT & Dental Emergencies

16 Chapter 15: Special Populations: Obstetrics & Neonatal Resuscitation

15.1 Antepartum Emergencies, Preeclampsia & Normal Spontaneous Childbirth 15.2 Complicated Deliveries: Breech, Prolapsed Cord, Nuchal Cord & Postpartum Hemorrhage 15.3 Neonatal Resuscitation Program (NRP) in the Prehospital Setting

17 Chapter 16: Special Populations: Pediatrics, Geriatrics, Palliative & Vulnerable Patients

16.1 Pediatric Assessment Triangle (PAT), Common Emergencies & Pediatric Dosing 16.2 Geriatric Syndromes, Polypharmacy, Elder Vulnerability & Falls 16.3 Palliative Emergencies, Medical Assistance in Dying (MAID) & Community Paramedicine 16.4 Bariatric Patients, Limited Mobility & Patients With Different Abilities

18 Chapter 17: Clinical Foundations — Terminology, Anatomy, Physiology & Pathophysiology

17.1 Medical & Paramedic Terminology, Abbreviations and Anatomical Reference 17.2 Applied Anatomy & Physiology Across Body Systems and the Lifespan 17.3 Core Pathophysiology: Cellular Injury, Hypoperfusion & the Shock States

19 Chapter 18: Pharmacology & Safe Medication Administration

18.1 Pharmacology Foundations: Classification, Pharmacokinetics & Pharmacodynamics 18.2 Safe Medication Administration: The Rights, Dose Calculation & Error Management 18.3 Medication Routes: Enteral, Parenteral, Inhaled & Topical Administration

20 Chapter 19: Vascular Access, Fluid Therapy, Routine Care & Patient Movement

19.1 Peripheral IV Cannulation, Venipuncture, Saline Locks & Maintaining Infusions 19.2 Intraosseous Access, Crystalloid Fluid Therapy, Pressure Infusers & Blood Products 19.3 Routine Care: Urinary Catheters, Ostomy & Drainage Systems, Chest Tubes & Wound Care 19.4 Patient Handling, Movement, Positioning & Transfer to a Higher Level of Care

21 Chapter 20: Mental Health, Behavioural Emergencies & Substance Use

20.1 Mental Status Assessment, Cognition & Capacity to Consent 20.2 Behavioural Emergencies, Severe Agitation & Safe Restraint 20.3 Substance Use, Addictions, Withdrawal & Harm Reduction

20.3 Substance Use, Addictions, Withdrawal & Harm Reduction

Key Takeaways Explain This Topic AI

Substance use disorder is a chronic health condition, and stigmatizing language measurably changes how clinicians manage the same case.

The Canadian unregulated supply is frequently adulterated with benzodiazepines and xylazine, neither reversed by naloxone, so continued sedation after adequate ventilation returns is expected rather than a failed reversal.

Naloxone is titrated to adequate ventilation, not to full wakefulness, and every reversed patient needs observation because of renarcotization.

Opioid withdrawal is rarely fatal, while alcohol and benzodiazepine withdrawal can kill; delirium tremens peaks at 48 to 96 hours and carries meaningful mortality.

The smell of alcohol explains nothing — head injury, hypoglycaemia, gastrointestinal bleeding, infection, and Wernicke encephalopathy are all more common in people with alcohol use disorder.

Last updated: September 2026

20.3 Substance Use, Addictions, Withdrawal & Harm Reduction

CPCF Appendix A skill #17 requires paramedics to recognize substance use, addictions, mental health and psychiatric conditions in patients , and knowledge #6 names healthy behaviours, disease prevention, harm reduction, quality of life as examinable content. Section 14.4 covers acute toxicology and naloxone pharmacology; this section covers the recognition of substance use disorders, the withdrawal syndromes, and the harm-reduction framework that Canadian paramedicine now operates within.

Substance Use Disorder Is a Health Condition

Substance use disorder is a chronic, relapsing health condition with genetic, neurobiological, developmental, and social contributors. Framing it as a moral failing produces measurably worse care: patients who anticipate judgement delay calling, conceal what they took, and leave before assessment is complete.

CPCF competencies that apply directly:

F1.2 — practise self-awareness to minimize personal and cognitive bias

F2.2 — use a trauma-informed approach to care, which matters here because the overlap between substance use and childhood trauma, violence, and homelessness is very high

  • F2.3 — adjust and accommodate care to promote equitable health outcomes
  • A1.1 — professional behaviours demonstrating compassion and respect

Language is a clinical tool. "A person who uses drugs" rather than "an addict" or "a user"; "substance use disorder" rather than "abuse"; "positive/negative toxicology" rather than "clean/dirty"; "a person with a substance use disorder" rather than "a substance abuser". These are not euphemisms — studies consistently show that clinicians shown identical case details described in stigmatizing language recommend more punitive and less therapeutic management.

The Canadian Toxic Drug Crisis

The unregulated drug supply in Canada is dominated by illicitly manufactured fentanyl and its analogues , now frequently adulterated with benzodiazepines (often called "benzo-dope") and with veterinary sedatives such as xylazine . Three consequences directly change paramedic practice:

Potency is unknown and inconsistent. A person cannot titrate a dose they cannot measure.

Benzodiazepine adulteration means naloxone may not fully reverse the presentation. The patient may resume breathing but remain deeply sedated, because naloxone has no effect on benzodiazepines. Continue ventilatory support and transport rather than concluding the reversal failed or that opioids were not involved.

Xylazine is not an opioid, does not respond to naloxone, and causes prolonged sedation, bradycardia, hypotension, and severe soft-tissue wounds.

Naloxone titration: the goal is restoration of adequate ventilation, not full wakefulness . Give incremental doses and support ventilation between them. Large rapid boluses precipitate acute withdrawal — agitation, vomiting with aspiration risk, and occasionally pulmonary oedema — and destroy the therapeutic relationship with a patient who then leaves before assessment. Renarcotization (Section 18.1) means every reversed patient needs observation and transport.

Withdrawal Syndromes

The examinable principle: opioid withdrawal is miserable but rarely fatal; alcohol and benzodiazepine withdrawal can kill. Candidates routinely have this backwards.

Opioid withdrawal Alcohol withdrawal Benzodiazepine withdrawal Stimulant withdrawal

Onset 6–12 h (short-acting); up to 30 h (methadone) 6–24 h 1–4 days (short-acting) to over a week Hours to days

Features Yawning, lacrimation, rhinorrhoea, piloerection, mydriasis, cramps, vomiting, diarrhoea, myalgia, intense craving Tremor, sweating, anxiety, tachycardia, hypertension, nausea; then seizures and hallucinations Anxiety, insomnia, tremor, perceptual disturbance, seizures Profound fatigue, hypersomnia, depression, suicidal ideation , hyperphagia

Life-threatening? Rarely — but dangerous in pregnancy (risk to the fetus) and in medically frail patients Yes Yes Risk is from suicide , not from the physiology

Peak danger — Delirium tremens at 48–96 h : confusion, agitation, hyperthermia, autonomic instability; significant mortality untreated Seizures may occur late and unexpectedly Days 1–3

Alcohol withdrawal seizures typically occur 6 to 48 hours after the last drink and may be the presenting event. Delirium tremens peaks at 48 to 96 hours and is a medical emergency with meaningful mortality even with treatment. Benzodiazepines are the definitive treatment; supportive care, thiamine considerations, glucose checking, and transport are the prehospital contribution.

Important

Never assume that a patient who smells of alcohol is simply intoxicated. People with alcohol use disorder have a high incidence of head injury, hypoglycaemia, gastrointestinal bleeding, infection, seizure, and thiamine deficiency (Wernicke encephalopathy — confusion, ataxia, ophthalmoplegia). The smell of alcohol explains nothing; it is a risk factor, not a diagnosis, and this is the reasoning error that appears most often in inquest findings.

Recognizing Substance Use Without Interrogating

Ask about all substances routinely and non-judgementally as part of the medication history: prescribed, over the counter, recreational, and natural or herbal (skill #15 names all four categories).

Normalize the question: "A lot of people use something to get through. Is there anything you're using that I should know about, so I don't give you something that interacts?" The framing makes disclosure useful rather than confessional.

Physical findings: injection sites and track marks, skin and soft-tissue infections, nasal septal damage, dental erosion, unexplained weight loss, repeated trauma, chronic hepatitis or HIV.

Contextual findings: paraphernalia, naloxone kits, missed appointments, frequent presentations.

Do not act shocked or write judgemental descriptions. What you record follows the patient through the health system and shapes how the next clinician approaches them.

Harm Reduction

Harm reduction is explicitly named in CPCF knowledge #6 and is a core part of Canadian public health policy. It aims to reduce the harms associated with substance use without requiring abstinence as a precondition for care.

Intervention What it does

Take-home naloxone Puts reversal in the hands of the people present at an overdose. Check whether the patient has a kit, and how to get one

Supervised consumption sites Reduce fatal overdose and transmission of blood-borne infection; know where they are in your service area

Needle and syringe programs Reduce HIV and hepatitis C transmission

Opioid agonist therapy (methadone, buprenorphine-naloxone) The most effective treatment for opioid use disorder; missed doses matter clinically

  • Drug checking services Let people identify fentanyl, benzodiazepine, and xylazine adulteration
  • Safer supply programs Provide a regulated alternative to the unpredictable toxic supply

Good Samaritan drug overdose legislation in Canada provides protection from charges for simple possession, and from some related breaches, for people who call emergency services at an overdose and for those at the scene. Paramedics should be able to explain this accurately, because fear of police is a leading reason people do not call — and a person who knows they will not be charged is a person who calls next time.

Practical harm reduction a PCP can deliver on any call:

Ask whether the patient has a naloxone kit and whether they know how to use it.

Advise on not using alone , and on the existence of overdose-prevention phone lines and apps.

Discuss reduced tolerance after any period of abstinence — after incarceration, hospitalization, or treatment. This is when most fatal overdoses occur and is among the highest-value pieces of information you can give.

Provide wound care and refer for infection (Sections 13.6 and 19.3); soft-tissue infection is a major cause of morbidity in this population.

Offer, and be able to name, the local referral pathways — withdrawal management, opioid agonist therapy, community health, Indigenous-led services.

Treat pain adequately. People who use opioids have high tolerance and real pain, and under-treating it is both a clinical failure and a reason people avoid calling.

When a Patient Declines Transport After an Overdose

This is a high-risk refusal, and it must be managed as a capacity assessment (Section 20.1), not as a formality:

Assess capacity specifically , recognizing that recent hypoxia and residual sedation impair it, and reassess after time has passed.

Explain renarcotization plainly : naloxone wears off in roughly 30 to 90 minutes while the opioid may last much longer, and the patient can stop breathing again.

Explain the specific risk of the adulterated supply , including benzodiazepine sedation that naloxone does not reverse.

Build a safety net: someone who will stay with them, a naloxone kit in the room, an agreement to call again, a follow-up contact.

Document thoroughly — the capacity assessment itself, what was explained, what the patient said, and the safety net arranged.

Leave the door open. How you treat someone at this refusal determines whether they call at all next time.